Skip to content
E99

Drawing based on the label description. No photo yet.

“Cefdinir Capsules 300 mg are lavender opaque/turquoise opaque size '0' hard gelatin capsule filled with off-white to yellow powder and imprinted with 'E99' on turquoise opaque body with black ink”

E99 pill

Pill with imprint E99 is purple & turquoise, capsule, 21 mm and has been identified as Cefdinir 300 mg. It is used for bronchitis, sinus infections and pneumonia. It is supplied by Rebel Distributors Corp.

Cefdinir 300 mg

Imprint
E99
Strength
300 mg
Used for
Bronchitis, sinus infections and pneumonia
Color
Purple, Turquoise
Shape
Capsule / oblong
Size
21 mm
Score
No score line
Form
Capsule
Manufacturer
Rebel Distributors Corp
Drug class
Antibiotic (cephalosporin)
NDC
21695-620, 65862-177, 21695-620-20, 52959-134, 52959-134-20, 54868-5767, 54868-5767-0, 54868-5767-1, 54868-5767-2, 54868-5767-3, 10544-194, 10544-194-20, 70934-044, 70934-044-20, 50090-1031, 50090-1031-3, 50090-1031-0, 50090-1031-1, 50090-1031-2, 61919-840, 57237-099, 61919-840-14, 61919-840-20, 68001-362, 68001-362-06, 53002-1526, 53002-1526-1, 53002-1526-2, 71205-224, 71205-224-14, 71205-224-20, 71205-224-30, 71205-224-60, 71205-224-90, 50090-2719, 50090-2719-1, 50090-2719-2, 50090-2719-3, 50090-2719-0, 65862-177-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cefdinir pills and guides

What is Cefdinir used for?

Cefdinir is used for bronchitis, sinus infections, pneumonia and ear infections.

Medicine type
Antibiotic (cephalosporin)
Official uses from the US prescribing label

To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir capsules and other antibacterial drugs, cefdinir capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Cefdinir capsules are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.

Adults and Adolescents

Community-Acquired Pneumonia

Caused by Haemophilus influenzae(including β-lactamase producing strains), Haemophilus parainfluenzae(including β-lactamase producing strains), Streptococcus pneumoniae(penicillin-susceptible strains only), and Moraxella catarrhalis(including β-lactamase producing strains) (see CLINICAL STUDIES ).

Acute Exacerbations of Chronic Bronchitis

Caused by Haemophilus influenzae(including β-lactamase producing strains), Haemophilus parainfluenzae(including β-lactamase producing strains), Streptococcus pneumoniae(penicillin-susceptible strains only), and Moraxella catarrhalis(including β-lactamase producing strains).

Acute Maxillary Sinusitis

Caused by Haemophilus influenzae(including β-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis(including β-lactamase producing strains).

NOTE:For information on use in pediatric patients, see Pediatric Use and DOSAGE AND ADMINISTRATION.

Pharyngitis/Tonsillitis

Caused by Streptococcus pyogenes (see CLINICAL STUDIES).

NOTE:Cefdinir is effective in the eradication of S. pyogenesfrom the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenespharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.

Uncomplicated Skin and Skin Structure Infections

Caused by Staphylococcus aureus(including β-lactamase producing strains) and Streptococcus pyogenes.

Pediatric Patients

Acute Bacterial Otitis Media

Caused by Haemophilus influenzae(including β-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis(including β-lactamase producing strains).

Pharyngitis/Tonsillitis

Caused by Streptococcus pyogenes(see CLINICAL STUDIES ).

NOTE:Cefdinir is effective in the eradication of S. pyogenesfrom the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenespharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.

Uncomplicated Skin and Skin Structure Infections

Caused by Staphylococcus aureus(including β-lactamase producing strains) and Streptococcus pyogenes.

From the FDA-approved label on DailyMed (published Aug 31, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows E99.
  • It is purple & turquoise, capsule, 21 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Cefdinir

Inactive: Carboxymethylcellulose Calcium, Silicon Dioxide, Magnesium Stearate, Fd&c Blue No. 1, D&c Red No. 28, Titanium Dioxide, Gelatin, Sodium Lauryl Sulfate, Ferrosoferric Oxide, Shellac

Also distributed by

H.j. Harkins Company, Inc., Physicians Total Care, Inc., Blenheim Pharmacal, Inc., Denton Pharma, Inc. Dba Northwind Pharmaceuticals, A-S Medication Solutions, Directrx, Bluepoint Laboratories, Rpk Pharmaceuticals, Inc., Proficient Rx LP, Aurobindo Pharma Limited, Rising Pharma Holdings, Inc., Nucare Pharmaceuticals,inc., Redpharm Drug, Pd-Rx Pharmaceuticals, Inc., Redpharm Drug, Inc., Coupler LLC, Direct_rx, Remedyrepack Inc., Preferred Pharmaceuticals Inc., Nucare Pharmaceuticals, Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Cefdinir pills